Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06294639
Other study ID # XJA-20240224
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 27, 2024
Est. completion date April 27, 2025

Study information

Verified date February 2024
Source Air Force Military Medical University, China
Contact Zhi-Hong Lu
Phone +862984775343
Email deerlu23@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

There is limited research on the combined use of esketamine and alfentanil for anesthesia during facial laser treatment in pediatric patients, and the effective dosage of esketamine for inhibiting body movement remains unclear. We explore the effective dose of esketamine combined with alfentanil for the inhibition of body movement during facial laser treatment in pediatric patients.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date April 27, 2025
Est. primary completion date March 27, 2025
Accepts healthy volunteers No
Gender All
Age group 3 Years to 12 Years
Eligibility Inclusion Criteria: - age between 3 years and 12 years old - patients scheduled for laser treatment of facial lesion Exclusion Criteria: - patients with airway infection during the last 1 month - patients with cardiac or pulmonary disorder - patients with hepatic or renal disfunction - patients with neurologic or psychiatric disorder

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Esketamine
esketamine will be given intravenously

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Air Force Military Medical University, China

References & Publications (3)

Su M, Zhu Y, Liu S, Song L, Qu J, Zhang Y, Zhang Q. Median effective dose (ED50) of esketamine combined with propofol for children to inhibit response of gastroscope insertion. BMC Anesthesiol. 2023 Jul 18;23(1):240. doi: 10.1186/s12871-023-02204-y. — View Citation

Zhang B, Li M, Han Y, Zhao X, Duan C, Wang J. Effective dose of propofol combined with intravenous esketamine for smooth flexible laryngeal mask airway insertion in two distinct age groups of preschool children. BMC Anesthesiol. 2024 Feb 5;24(1):50. doi: 10.1186/s12871-024-02421-z. — View Citation

Zheng XS, Shen Y, Yang YY, He P, Wang YT, Tao YY, Zheng JJ, Sun Y. ED50 and ED95 of propofol combined with different doses of esketamine for children undergoing upper gastrointestinal endoscopy: A prospective dose-finding study using up-and-down sequential allocation method. J Clin Pharm Ther. 2022 Jul;47(7):1002-1009. doi: 10.1111/jcpt.13635. Epub 2022 Mar 7. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary half effective dose of inhibition of body movement from injection of esketamine to start of laser treatment, in an average of 5 minutes
Secondary number of patients with agitation during awake from end of injection of esketamine to 30 minutes after laser treatment, in an average of 60 minutes
Secondary number of patients with dizzy during awake from end of injection of esketamine to 30 minutes after laser treatment, in an average of 60 minutes
Secondary number of patients with nausea and vomiting during awake from end of injection of esketamine to 30 minutes after laser treatment, in an average of 60 minutes
Secondary number of patients with apnea during awake from end of injection of esketamine to 30 minutes after laser treatment, in an average of 60 minutes
Secondary satisfaction score of the parents to the anesthesia The satisfaction of the parents to the anesthesia will be assessed by visual analogue scale, of which 0 is for extremely not satisfied, 10 is for extremely satisfied from end of laser treatment to discharge from the outpatient unit, in an average of 60 minutes
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04580030 - Tricuapid Annular Plane Sistolic Excursion Before General Anesthesia Can Predict Hypotension After Induction
Active, not recruiting NCT04279054 - Decreased Neuraxial Morphine After Cesarean Delivery Early Phase 1
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Recruiting NCT04099693 - A Prospective Randomized Study of General Anesthesia Versus Anesthetist Administered Sedation for ERCP
Terminated NCT02481999 - Pre- and Postoperative EEG-Monitoring for Children Aged From 0,5 to 8 Years
Completed NCT04235894 - An Observer Rating Scale of Facial Expression Can Predict Dreaming in Propofol Anesthesia
Recruiting NCT05525104 - The Effect of DSA on Recovery of Anaesthesia in Children (Het Effect Van DSA op Het Herstel na Anesthesie Bij Kinderen). N/A
Recruiting NCT05024084 - Desflurane and Sevoflurane Minimal Flow Anesthesia on Recovery and Anesthetic Depth Phase 4
Completed NCT04204785 - Noise in the OR at Induction: Patient and Anesthesiologists Perceptions N/A
Completed NCT03277872 - NoL, HR and MABP Responses to Tracheal Intubation Performed With MAC Blade Versus Glidescope N/A
Terminated NCT03940651 - Cardiac and Renal Biomarkers in Arthroplasty Surgery Phase 4
Terminated NCT02529696 - Measuring Sedation in the Intensive Care Unit Using Wireless Accelerometers
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Terminated NCT03704285 - Development of pk/pd Model of Propofol in Patients With Severe Burns
Recruiting NCT05259787 - EP Intravenous Anesthesia in Hysteroscopy Phase 4
Completed NCT02894996 - Does the Response to a Mini-fluid Challenge of 3ml/kg in 2 Minutes Predict Fluid Responsiveness for Pediatric Patient? N/A
Completed NCT05386082 - Anesthesia Core Quality Metrics Consensus Delphi Study
Terminated NCT03567928 - Laryngeal Mask in Upper Gastrointestinal Procedures N/A
Recruiting NCT06074471 - Motor Sparing Supraclavicular Block N/A
Completed NCT04163848 - CARbon Impact of aNesthesic Gas